Mayo Clinic Joins US Army’s AFIRM Phase II Initiative.

The Mayo Clinic aims to develop nerve regeneration therapies for wounded veterans.

Researchers from the Mayo Clinic have joined the Army’s Afirm II [Armed Forces Institute of Regenerative Medicine] program. AFIRM spearheads a national consortium of advanced research centers developing regenerative medical therapies to care for and treat the injuries of severely wounded army veterans. Mayo Clinic researchers will focus on peripheral nerve regeneration.

Over the next five years AFIRM II will utilize the unique properties of stem cells to regenerate and restore function in tissue and organs damaged from battlefield injuries. The treatments that result from this project will serve civilian trauma and burn patients as well. Dr. Andre Terzic, a specialist in regenerative medicine at the Mayo Clinic, states, “The Mayo Clinic Center for Regenerative Medicine is honored to partner in this national effort poised to transform the care of severely wounded veterans. Advances in regenerative technologies promise unprecedented benefits for patients, their families and society.”

Innovative projects like AFIRM II demonstrate the integral role stem cell therapies will soon play in cutting edge medical care options. By banking their own valuable stem cells, families can ensure that they will have access to these emerging therapies in the near future. To learn more about banking stem cells, please visit www.stemsave.com or call 877-783-6728 (877-StemSave) today.

 

To view the full article, click here.

 

The Future of Regenerative Medicine is Now™